JP2016191804A - Medicine information display label for medicine container attachment and medicine container filled with medicine provided with the same - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a medicine information display label for medicine container attachment which enables a user to easily and surely confirm the shift of medicine in a medicine container to an administration container and to urge attention drawing when medicine is not shifted.SOLUTION: A medicine information display label 1 for medicine container attachment includes a lower side sheet 2 for being stuck to a medicine container, and an upper side sheet 3 which covers the surface of the lower side sheet 2 and can be stuck peelably to an administration container after being peeled. The upper side sheet 3 includes an upper side sheet side use state display 33 which is difficult to be visually recognized before being peeled from the lower side sheet 2 and can be visually recognized after being peeled.SELECTED DRAWING: Figure 1

Description

  The present invention relates to a drug information display label attached to a drug container and a drug-filled drug container including the same.

In a drug container containing a drug, it is desirable that the use and non-use of the stored drug can be clearly and easily grasped. For example, in the field of anesthesiology, there are many opportunities to use powerful drugs, poisons, etc. as drugs, and there are many cases where prompt decision and prompt decision are required. In addition, since drugs mainly consist of intravenous and intravenous infusions, active ingredients directly enter the systemic blood and exhibit drug efficacy. is necessary.
For example, there is a case where a vial containing a medicine is prepared in advance, and the medicine in the vial is mixed and administered to a prefilled syringe filled with a diluent such as physiological saline prepared separately. There is a risk of misadministration such as administration even though the drug has not been formulated.

The following are known as labels for preventing such misadministration.
A label 1 attached to a container for storing a medicine described in Japanese Patent No. 5597424 (Patent Document 1) includes a base layer label 2 and a small label piece 3 on which a drug name is affixed to a partial area thereof. Consists of. When the medicine in the container is dissolved and injected, the small label piece 3 is peeled off and attached to the syringe. Character information 24 indicating that the medicine has been dissolved is described at the place where the small label piece 3 in the base layer label 2 is peeled off.

  Moreover, utility model registration No. 3149156 (patent document 2) is proposed, and the prefilled syringe 1 of this patent document 2 includes a first display label 81 provided on the outer surface of the outer cylinder main body portion 21, and a first display label 81. And a second display label affixed to the outer surface of the display label 81. The first display label 81 includes a medicine name recordable portion. The second display label has a display part indicating that it is a drug solution on the surface, and is peeled off from the outer surface of the first display label 81 so as to cover the drug name recordable part of the first display label 81 It is affixed as possible.

  In Patent Document 1 and Patent Document 2, the small label piece 3 is peeled off from the base layer label 2 and the second display label is peeled off from the first display label 81, respectively, and another container or the like (for example, a prefilled syringe or It can be transferred to a drip infusion bag or the like. The small label piece 3 or the second display label covers the dissolved label or the like written on the base layer label 2 or the first display label 81, and the small label piece 3 or the second display label By peeling off, it is surely and easily alerted by a display such as dissolved. The peeled small label piece 3 or the second display label is attached to a syringe or the like so that a warning display such as “mixed” can be described.

Japanese Patent No. 5597424 Utility Model Registration No. 3149156

  In the above-described conventional device, the small label piece 3 or the second display label is peeled off, so that the warning display such as dissolved already covered on the base layer label 2 or the first display label 81 can be surely and easily performed. In the small label piece 3 or the second display label that can be displayed but can be transferred to other containers, a warning display such as “Pre-mixed” or drug name is added by hand. There is a need. For this reason, the work of filling in the small label piece 3 or the second display label is complicated, and it may become unclear whether the filling work has been forgotten because of the filling work. For this reason, there still remains a risk of erroneous administration even if the medicine in the vial is not already formulated.

  An object of the present invention is to provide a drug container labeling drug information display label that can easily and surely confirm the movement of a drug in a drug container to an administration container, and can prompt an unmoving alert in the drug container label, and A drug-filled drug container including the same is provided.

What achieves the above object is as follows.
(1) A drug information display label for sticking to a drug container,
The drug information display label includes a lower sheet to be affixed to a drug container, and an upper sheet that partially or entirely covers the surface of the lower sheet, and can be peeled and affixed to the administration container after peeling. And
The said upper sheet | seat is a chemical | medical agent sticking chemical | medical agent information display label provided with the upper sheet | seat side use condition display which becomes difficult to visually recognize before peeling from the said lower sheet, and becomes visible after peeling.

(2) The medicine sheet sticking medicine information display label according to (1), wherein the upper sheet usage status display is character information indicating that a medicine is blended.
(3) The upper sheet usage status display includes colored character information surrounded by the transparent portion or transparent character information provided in the colored portion,
The said lower sheet is located in the lower part of the said upper sheet usage condition display of the said upper sheet before peeling from the said lower sheet, and is provided with the visual recognition control part which prevents visual recognition of the said character information (1) The drug information display label attached to the drug container according to 1.
(4) The medicine container sticking medicine information display label according to (3), wherein the visual restriction unit has a color that is difficult to distinguish from the color of the character information.
(5) The drug container according to any one of (1) to (4), wherein the upper sheet is provided with an upper sheet side drug information display that describes information on a drug stored in the drug container on the surface. Adhesive drug information display label.

(6) The lower sheet has a peelable printing portion provided at a lower portion of the upper sheet side usage status display of the upper sheet before being peeled from the lower sheet, and the upper sheet side usage status The display is a drug information display label attached to the drug container according to the above (2), in which the necessary character information is peeled off from the peelable print section when the upper sheet is peeled off.
(7) The lower sheet is visible after the upper sheet is peeled off, and includes the lower sheet side usage status display that can be inferred that the medicine has been used (1) to (6) The medicine container display drug information display label according to any one of the above.
(8) The drug information display label attached to the drug container according to (7), wherein the lower sheet side usage status display is character information indicating that the drug has been used.
(9) The said lower sheet is provided with the lower sheet | seat side chemical | medical agent information display which described the information regarding the chemical | medical agent accommodated in the said chemical | medical agent container on the surface. Drug information display label attached to the drug container.

Moreover, what achieves the said objective is as follows.
(10) A medicine container having a container body and a medicine stored in the container body, and the medicine container according to any one of (1) to (9) attached to the medicine container A label-filled drug container filled with a sticking drug information display label.

(11) The medicine container in which the medicine is stored includes a sealing portion that seals an opening included in the container body, and the sealing portion includes an elastic seal member that can be punctured by the puncture member, Is a cylindrical main body having an opening tip, and the medicine container in which the medicine is stored has a sealing portion for sealing the opening tip of the container main body and the cylindrical main body in a liquid-tight state. The label according to (10), wherein the drug information display label attached to the drug container is provided with a peeling promotion display that promotes peeling located on the distal end side of the container main body. Pre-filled drug container.
(12) The label-containing drug-filled drug container according to (11), wherein the peeling promotion display is easily visible or visible when the gasket moves to the site.
(13) The lower sheet of the medicine information label attached to the medicine container is provided with a pre-combination display indicating that it is a pre-combination provided at the gasket arrangement position, and the pre-combination display is visually recognized by the gasket. (11) or (12), the label-containing drug-filled drug container according to the above.
(14) The lower sheet is provided with a lower sheet side usage status display provided so as to be positioned on the gasket, and the lower seat side usage status display is difficult to visually recognize when the gasket is positioned. Then, the label-containing drug-filled drug container according to (11) or (12), which is visible when the gasket moves.

The drug information display label to be affixed to the drug container of the present invention covers the lower sheet for affixing to the drug container and the surface of the lower sheet partially or entirely, and can be peeled and affixed to the administration container after peeling. And an upper sheet that is possible. The upper sheet is difficult to visually recognize before peeling from the lower sheet, and is provided with an upper sheet side usage status display that becomes visible after peeling.
The display label of the present invention is used by sticking to a drug container containing a drug, and after the operation of moving the drug in the drug container to the administration container is finished, the upper sheet is peeled from the lower sheet, By sticking, the administration container can have an upper sheet. Furthermore, since the upper sheet side usage status display appears on the upper sheet attached, it can be easily recognized that the medicine is blended in the administration container. Further, in this display label, the upper sheet side usage status display is difficult to visually recognize before the upper sheet is peeled off, so that an unused medicine container is not mistaken for a used one.

FIG. 1 is a front view of a drug information display label attached to a drug container according to an embodiment of the present invention. FIG. 2 is a front view of the lower sheet after the upper sheet is peeled off from the display label shown in FIG. 1. FIG. 3 is a front view of the upper sheet peeled off from the display label shown in FIG. 1. FIG. 4 is a front view of an upper sheet used for a drug information display label attached to a drug container according to another embodiment of the present invention. FIG. 5 is a front view of a drug information display label attached to a drug container according to another embodiment of the present invention. FIG. 6 is a front view of the lower sheet after the upper sheet is peeled from the display label shown in FIG. 5. FIG. 7: is a front view of the chemical | medical agent container sticking chemical | medical agent information display label of the other Example of this invention. FIG. 8 is a front view of the upper sheet peeled off from the display label shown in FIG. FIG. 9 is a front view of the lower sheet after the upper sheet is peeled off from the display label shown in FIG. 7. FIG. 10 is a front view of a drug container filled with a label-containing drug according to an embodiment of the present invention. FIG. 11 is an explanatory diagram for explaining the operation of the label-containing drug-filled drug container shown in FIG. FIG. 12 is a front view of a label-containing drug-filled drug container and an administration container used therefor according to another embodiment of the present invention. 13 is an enlarged longitudinal sectional view of the label-containing drug-filled drug container shown in FIG. 14 is an enlarged longitudinal sectional view of the administration container shown in FIG. FIG. 15 is an explanatory diagram for explaining the operation of the label-containing drug-filled drug container and administration container shown in FIG. FIG. 16 is an explanatory diagram for explaining the operation of the administration container shown in FIG. FIG. 17 is a front view of a label-containing drug-filled drug container according to another embodiment of the present invention. FIG. 18 is a front view of a label-containing drug-filled drug container according to another embodiment of the present invention. FIG. 19 is a front view of a label-containing drug-filled drug container according to another embodiment of the present invention. FIG. 20 is an explanatory diagram for explaining the operation of the medicine container shown in FIG. FIG. 21 is a front view of a label-containing drug-filled drug container according to another embodiment of the present invention. FIG. 22 is a view showing a state where the upper sheet is peeled from the medicine container shown in FIG. FIG. 23 is an explanatory diagram for explaining the operation of the medicine container shown in FIG. FIG. 24 is a front view of a label-containing drug-filled drug container according to another embodiment of the present invention. FIG. 25 is an explanatory diagram for explaining the operation of the medicine container shown in FIG. FIG. 26 is a front view of a label-containing drug-filled drug container according to another embodiment of the present invention.

The display label of this invention is demonstrated using the Example shown on drawing.
The drug information display label 1 attached to the drug container of the present invention includes a lower sheet 2 to be applied to the drug container, a lower sheet 2 to be applied to the drug container, and a surface of the lower sheet 2 partially or It is provided with an upper sheet 3 that is entirely covered, can be peeled off, and can be attached to the administration container after peeling.

The upper sheet 3 includes an upper sheet side usage status display 33 that is difficult to visually recognize before peeling from the lower sheet 2 and is visible after peeling.
As shown in FIGS. 1 to 3, the drug container sticking drug information display label 1 of this embodiment includes a lower sheet 2 and an upper sheet 3 attached to the surface of the lower sheet 2. The lower sheet 2 is in the form of a film having an adhesive surface for attaching a drug container on the lower surface.

  The upper sheet 3 is provided with an adhesive surface (not shown) for sticking to the surface of the lower sheet 2 on the lower surface, and this adhesive surface can be peeled off from the lower sheet and is also adhesive after peeling. Sex is to be maintained. For this reason, the upper sheet 3 can be peeled and can be stuck to the administration container after peeling. As the adhesive surface, an adhesive substance such as a pressure sensitive adhesive can be used. Further, the adhesive surface may be configured to be peelable and re-applicable by part-coating such an adhesive substance on the lower surface. The upper sheet 3 is peelable from the lower sheet 2 and then pasted to another place, that is, transferable.

  In the label 1 of this embodiment, as shown in FIG. 1, the surface of the lower sheet 2 is partially covered with the upper sheet 3 instead of being entirely. For this reason, the lower sheet 2 is provided with an exposed portion, and a lower sheet side drug information display 22 describing information on the drug stored in the drug container is provided in the exposed portion. In this embodiment, the lower sheet side drug information display 22 displays a drug name and a drug amount. The information display 22 may further display necessary information, for example, the type of medicine and the administration type.

  In the label 1 of this embodiment, as shown in FIGS. 1 and 3, the upper sheet 3 partially covers the lower sheet 2. And the upper sheet | seat 3 is provided with the upper sheet | seat side chemical | medical agent information display 32 on the surface. In this embodiment, the upper sheet side drug information display 32 displays the drug name and the drug amount. The information display 32 may further display necessary information, for example, the type of medicine, the administration type, and the like.

  And in the label 1 of this Example, as shown in FIG. 2, the lower sheet | seat 2 is provided with the lower sheet | seat side use condition display 24 provided in the surface site | part coat | covered with the upper sheet | seat 3. As shown in FIG. The lower sheet side usage status display 24 is not visible before the upper sheet 3 is peeled off, and is exposed and visible after the peeling. The lower sheet side usage status display 24 is a display that can be used to infer that the medicine has been used. Specifically, a character display indicating that the medicine has been used (for example, “used” )) Is used. In addition, at least a portion of the base portion 31 of the upper sheet 3 that covers the lower sheet side usage status display 24 cannot be seen through.

  Further, in the label 1 of this embodiment, as shown in FIG. 3, the upper sheet 3 includes an upper sheet side usage status display 33. The upper sheet side usage status display 33 is difficult to visually recognize before peeling from the lower sheet 2 and is visible after peeling. The upper sheet side usage status display 33 is a blending information display that indicates that the medicine has been blended. Specifically, a character display (for example, “blended” indicating that the medicine has been blended) is displayed. )) Is used.

  Moreover, in the label 1 of this Example, in order to make it difficult to visually recognize the above-mentioned upper sheet side usage status display 33 before the upper sheet is peeled off, the upper sheet side usage status display (formulation information display) 33 is a transparent portion. The lower sheet 2 includes a visual restriction portion 23 that is positioned below the upper sheet side usage status display 33 of the upper sheet 3 and prevents visual recognition of the character information. Moreover, the upper sheet | seat side use condition display 33a may have transparent character information in a coloring part like the upper sheet | seat 30 shown in FIG.

The visual restriction part 23 is created, for example, by providing a printing part (printing area) of a color that is difficult to distinguish from the color of the character information in the upper sheet side usage status display 33 of the upper sheet 3.
In the label 1 of this embodiment, as shown in FIG. 2, the lower sheet side medicine information display 22 described above is provided above the base portion 21 of the lower sheet 2, and one of the information displays below the information display is displayed. The lower sheet side usage status display 24 described above is provided on the side portion, and the visual restriction portion 23 is painted on the other side portion with the color that is difficult to identify (in this example, a predetermined single color). Is provided.

  In addition, in the modified Munsell color system by the American Optical Society, a color that is difficult to identify is a difference in hue, lightness, and saturation due to one Munsell value display. It is preferable to select a range within 0 and a range within 3.0 of saturation. For example, if one color scheme is Munsell value display (hue lightness / saturation) and 7.5 YR 8.0 / 4.0, the other color scheme has a hue of 6.5 to 8.5 YR and a lightness of 7. A color having a range of 0 to 9.0 and a saturation of 1.0 to 7.0 is preferably used. In addition, in the saturation, when the saturation of the other “range within 3.0” exceeds the upper limit value or the lower limit value of one saturation, the range of the upper limit value or the lower limit value is set. The other “range within 3.0 of saturation”. Also in each of the following examples, the “difficult colors” are preferably those described above.

Moreover, it is preferable that the upper sheet side usage status display 33 and the lower sheet side medicine information display 22 are arranged in different colors. By doing in this way, the difference of the said display can be recognized easily.
Further, the color of the upper sheet side usage status display 33 (character color or the color of the colored portion surrounding the transparent character information) can be easily identified with respect to the color of the administration container when the upper sheet 3 is transferred. It is preferable that it is a thing. Specifically, the color of the upper sheet side usage status display 33 is preferably a color different from the color of the administration container at the time of use (a range outside the range of the Munsell value display described above), and moreover, a complementary color relationship It is preferable to use a color as shown in FIG.

  And in the label 1 of this Example, as shown in FIG.1 and FIG.3, the upper sheet | seat 3 has the extension part 34 which is not affixed on the lower sheet | seat 2, or has become very easy to peel. I have. The extending portion 34 protrudes outward from the side portion of the base portion 31 and is used as a grip portion during the peeling operation of the upper sheet 3. Specifically, as shown in FIG. 3, the upper sheet 3 includes a base portion 31 that is formed in a horizontally long rectangular shape, and an extending portion 34 that extends from the left end portion of the base portion 31. Yes. In the extending portion 34, an arrow or the like is written so that the user can easily recognize the part to be picked and the direction in which the user peels can be easily recognized to improve the convenience of the peeling work of the upper sheet 3. Also good.

  Moreover, the back surface of the lower sheet 2 is preferably provided with a patch layer and further a release paper is pasted thereon. Moreover, as a label (upper sheet, lower sheet), a standard color and printable film, paper, or the like can be used. In addition, in the lower sheet 2 and the upper sheet 3, in addition to the drug-related information, for example, the manufacturer name, usage, expiration date, and the like may be described. In addition, the upper sheet and the lower sheet are preferably displayed on the front surface of each sheet, but may be printed on the back surface.

  In the embodiment described above, the positions of the base portion 21 and the lower sheet side usage status display 24 of the lower seat 2 and the positions of the upper seat side usage status display 33 of the upper sheet 3 are as described above. The base portion 21 and the upper sheet side usage status display 33 overlap with each other, and the lower sheet side usage status display 24 is covered with the upper sheet 3 as appropriate on the lower sheet 2 and the upper sheet 3. It may be changed and arranged. In addition, as for the usage status display, display of an appropriate language, type, and content can be selected depending on the use of the display label. Moreover, it is good also as a figure not only a character.

  Moreover, as an upper sheet | seat, you may cover the substantially whole surface of the lower sheet | seat 2 like the label 1a shown in FIG. 5 and FIG. The upper sheet 3a of the label 1a covers the above-described lower sheet side medicine information display 22 of the lower sheet 2 and is invisible. In addition, in this label 1a, by peeling off the upper sheet 3a, the lower sheet side medicine information display 22 described above of the lower sheet 2 is exposed and becomes visible as in the case shown in FIG. .

Moreover, as a chemical | medical agent container sticking chemical | medical agent information display label, what is shown to FIG. 7 thru | or FIG. 9 may be used.
In the medicine container sticking medicine information display label 1b of this embodiment, the lower sheet 2b has a peelable printing part 27 provided at the lower part of the upper sheet side usage status display 33b of the upper sheet 3b, and the upper sheet side. The usage status display 33b peels off necessary character information from the peelable printing unit 27 when the upper sheet 3b is peeled off. Then, as shown in FIG. 8, the upper sheet side usage status display 33b of the upper sheet 2b is formed by character information peeled off from the peelable printing unit 27 when the upper sheet 3b is peeled off. Further, as shown in FIG. 9, the lower sheet side usage status display of the lower sheet 2 b is formed by character information traces peeled off from the peelable printing unit 27 when the upper sheet 3 b is peeled off. Yes.

Next, the label-containing drug-filled drug container 10 shown in FIG. 10 will be described.
The label-containing drug-filled drug container 10 includes a drug container that has a container main body 11 and a drug 13 that is stored in the container main body 11, and a drug container affixed drug information display that is affixed to the drug container. It consists of label 1. In addition, as a medicine information display label, you may use the thing of any Example mentioned above. In the illustrated example, the label 1 described above is used. The drug container 10 is a vial container that stores a drug.

  In addition, the medicine container 10 with the medicine stored in this embodiment includes a sealing portion 12 that seals an opening provided in the container main body portion 11. And the sealing part 12 is provided with the elastic sealing member 18 which a puncture member can puncture.

  The container main body 11 may be anything as long as it has an opening and can store a medicine inside. For example, a rigid or semi-rigid synthetic resin container, a glass container, or the like is used. The illustrated container body 11 includes a cylindrical portion whose lower end is closed and an opening having a thick flange. An elastic seal member 18 is attached to the opening, and an encapsulation member 19 that encloses the peripheral edge of the elastic seal member 18 is provided.

  Although it does not restrict | limit especially as the chemical | medical agent 13, For example, protein preparations, such as platinum type anticancer agent and insulin, nitroglycerin, isosorbide nitrate, nicardipine hydrochloride, monoammonium glycyrrhizinate, a protein preparation, an antitumor agent, a vitamin agent ( Multivitamin preparation), various amino acids, antithrombotic agents such as heparin, insulin, antibiotics, antitumor agents, analgesics, cardiotonic agents, intravenous anesthetics, antiparkinsonian agents, ulcer treatments, corticosteroids, arrhythmia Agents and the like. Also, the dosage form of the drug is not particularly limited and may be any liquid drug, powder drug, lyophilized drug, solid drug, and the like.

And the above-mentioned label 1 is stuck on the front of the container main body 11.
As shown in FIGS. 1 and 10, both the upper sheet side medicine information display 32 and the lower sheet side medicine information display 22 are visible from the label 1, but the upper sheet side usage status display 33 and the lower sheet are visible. None of the side usage status displays 24 is visible.

  As shown in FIG. 10, the display label 1 is attached in advance to the side portion of the medicine container 10 in a state where the upper sheet 3 is attached to the lower sheet 2. In a state where the upper sheet 3 covers the lower sheet 2, the upper sheet side usage status display 33 (characters “mixed”) is sufficiently transmitted to the user by the identification restricting portion 23 of the lower sheet 2 that is transmitted. I can't recognize it. Further, since the lower sheet side usage status display 24 (characters “used”) is covered with the base portion 31 of the upper sheet 3, the user cannot visually recognize it. Therefore, the user can recognize that the medicine container 10 is unused.

  Then, as shown in FIG. 11, a syringe 50 having a puncture member (specifically, an injection needle 14) attached to the tip and filled with a diluent (for example, water for injection and physiological saline) is prepared. This is connected to the above-mentioned drug container 10 (specifically, the injection needle 14 is punctured into the elastic seal member 18. Then, the drug in the drug container 10 is sucked into the syringe, and the drug in the drug container 10 is removed. It mixes with the dilution liquid of the syringe 50. After mixing a chemical | medical agent, the upper sheet | seat 3 is peeled from a chemical | medical agent container, and it affixes on the side surface of the outer cylinder of the syringe 50. Thereby, an upper sheet | seat side chemical | medical agent information display 32 and an upper sheet | seat. A syringe filled with a medicine to which an upper sheet having a side usage status display 33 (specifically, “mixed”) is attached is prepared, and the medicine container 10 from which the medicine has been discharged has a lower sheet side. Drug information display 2 And the lower sheet side usage status display 24 (specifically, “used”) are left in the state where the lower sheet 3 is left. Therefore, it can be surely recognized that the medicine has been blended.

  Since the medicine-filled syringe 50 having the upper sheet has the character information 33 “mixed” together with the medicine information, it can be easily recognized that the medicine in the medicine container 10 has been added. In this embodiment, the “mixed” character display 33 is surrounded by a transparent portion. Further, the upper sheet side usage status display 33 is created in a color that can be recognized at the time of sticking to the syringe.

  In the upper sheet 3 peeled from the lower sheet 2, since the periphery of the upper sheet side usage status display 33 (character of “mixed”) is transparent, the syringe 50 that can be seen through through the periphery The upper sheet side usage status display 33 (characters “mixed”) of different colors can be clearly recognized by the user. Further, for example, in the display label 1, the upper sheet 3 is peeled from the lower sheet 2 and the syringe is compared with the display label that needs to be described as “already blended” by a writing tool on the label sub-piece portion after transfer. By simply transferring to 50, the upper sheet side usage status display 33 (letters “mixed”) can be displayed reliably and easily, and there is very little risk of misadministration due to forgetting the description.

  On the other hand, in the lower sheet 2 stuck to the medicine container 10, as a result of the upper sheet 3 being peeled off, the lower sheet side usage status display 24 ("" "Used" characters) are exposed. Therefore, the user can clearly recognize that the medicine container 10 has been used. Further, since the lower sheet side usage status display 24 is exposed only by peeling the upper sheet 3, the user can be made aware of the usage status without requiring any special work. For this reason, it is possible to reliably perform necessary processing such as disposal of the drug container 10 that has become “used” by mixing the drug into the syringe 15.

Next, the label-containing drug-filled drug container 40 shown in FIGS. 12 to 16 will be described.
The label-containing medicine-filled medicine container 40 is composed of a medicine container having a container body 41 and a medicine 48 contained in the container body 41, and a medicine container affixing medicine information display attached to the medicine container. It consists of label 1. In addition, as a medicine information display label, you may use the thing of any Example mentioned above. In the illustrated example, the label 1 described above is used. The drug container 40 is an administration container used at the time of use, and is set with a syringe 15 to which the peeled upper sheet 3 is transferred.

The container main body 41 is a cylindrical main body (barrel) having an opening tip 45, and the medicine container in which the medicine is stored includes a sealing portion 46 that seals the opening tip of the container main body 45, and a cylinder. And a gasket 42 that is slidable in a liquid-tight state.
The container main body 41 includes a cylindrical main body that penetrates from the distal end to the proximal end, a nozzle-shaped distal opening 45, a flange 44 provided at the proximal end, and a collar portion 43 that encloses the distal opening 45. Is provided. The container body 41 may be any container as long as it has an opening and can store the medicine 48 inside. For example, the outer cylinder forming material described above, such as a rigid or semi-rigid synthetic resin container or a glass container, is used.

  As the drug, a drug that can be dissolved in the medical liquid 17 filled in the syringe 15 to be used is used, and any drug such as a powder drug, a freeze-dried drug, a solid drug, and a liquid drug may be used. . Examples of drugs include vitamins (general vitamins), various amino acids, antithrombotics such as heparin, insulin, antibiotics, antitumor agents, analgesics, cardiotonic agents, intravenous anesthetics, antiparkinson agents, and ulcer treatments Agents, corticosteroids, arrhythmic agents, hormone preparations, interferon preparations, human immunoglobulin preparations, blood coagulation factor preparations, vaccine preparations, and other protein preparations.

  As shown in FIGS. 12 and 13, a sealing portion 46 is attached to the distal end opening 45 of the container main body 41, and the container main body 41 is sealed in a liquid-tight state. As shown in FIG. 12, the sealing portion 46 includes a disk-shaped main body portion, and a cylindrical portion 46 a that protrudes from the main body portion and can enter the collar portion 43 and the tip opening 45 of the container main body portion 41. ing.

The syringe 15 includes an outer cylinder 6, a gasket 8 that is accommodated in the outer cylinder 6 and that can slide in a liquid-tight state, a medical liquid 17 that is filled in the outer cylinder 6, and a proximal end of the gasket 8. A plunger 7 attached to the adapter 16, an adapter 16 attached to the tip of the outer cylinder 6 having the nozzle 62, and a sealing member 9 that seals the tip of the outer cylinder 6 to which the adapter 16 is attached. .
The syringe 15 is not limited to the prefilled syringe as described above, and a normal syringe may be used. In this case, the syringe is not filled with medical liquid and does not include a sealing member. When such a normal syringe (empty syringe) is used, it is used after a medical liquid such as physiological saline or water for injection, which has been separately prepared, is sucked into the syringe at the time of use.

The nozzle portion 62 of the outer cylinder 6 of the syringe 15 protrudes from the shoulder portion of the main body portion 61 in the distal direction. Further, as shown in FIG. 14, the distal end portion of the outer cylinder 6 includes a collar portion 63 that encloses the nozzle portion 62. An outer cylinder side screwing portion is formed on the inner surface of the collar portion 63. In this embodiment, the outer cylinder 6 includes an outer cylinder side screwing portion, and an outer cylinder connection portion of the adapter 16 described later includes an adapter side screwing portion that can be screwed with the outer cylinder side screwing portion. .
As shown in FIG. 14, the gasket 8 includes a main body portion extending with substantially the same outer diameter and a plurality of annular ribs provided on the main body portion, and these ribs are formed on the inner surface of the main body portion 61 of the outer cylinder 6. Move with close contact. The gasket 8 includes a plunger mounting portion at the base end portion.

As shown in FIG. 12 and FIG. 14, the plunger 7 includes a main body portion 71 extending in the axial direction having a cross-shaped cross section, a gasket mounting portion 72 provided at the distal end portion, and a pressing portion provided at the proximal end portion of the main body portion. Part 73.
The medical liquid 17 filled in the syringe 15 contains a drug solution such as distilled water for injection, physiological saline, and aqueous glucose solution, and further contains a drug (for example, vitamins and minerals). The chemical | medical solution which can melt | dissolve the chemical | medical agent in the container 40 may be sufficient.

  As shown in FIGS. 14 and 15, the adapter 16 is a cylindrical body that penetrates from one end to the other end, and includes an outer cylinder connecting portion 95 that is attached to the distal end portion of the outer cylinder 6 on one end side. On the other end side, a drug container connecting portion 94 that can be connected to the tip opening of the container main body 41 is provided. And as shown in FIG.14 and FIG.15, the outer cylinder 6 with which the adapter 16 was mounted | worn is a thing which the nozzle part 62 does not expose.

  The outer cylinder connecting portion 95 of the adapter 16 can enter between the nozzle portion 62 and the collar portion 63 of the outer cylinder 6. Further, on the outer surface of the outer cylinder connecting portion 95, an adapter side screwing portion that can be screwed with the outer cylinder side screwing portion of the outer cylinder 6 is provided. Furthermore, the adapter 16 includes an annular rib that is provided on the inner surface and contacts the outer surface of the nozzle portion 62 of the outer cylinder 6 in a liquid-tight state.

  The adapter 16 includes a cylindrical drug container connecting portion 94 that can accommodate the distal end portion of the distal end opening of the container main body 41 on the other end side. The medicine container connecting portion 94 is capable of entering between the distal end opening 45 and the collar portion 43 of the container main body portion 41. Furthermore, the adapter 16 includes an annular rib that contacts the outer surface of the tip opening 45 of the container body 41 in a liquid-tight state. For this reason, as shown in FIG. 15, the adapter 16 can connect the container main body 41 in a liquid-tight state.

  And as shown in FIG. 14, the sealing member 9 is attached to the outer cylinder 6 to which the adapter 16 is connected, and the outer cylinder 6 is sealed in a liquid-tight state. As shown in FIG. 14, the sealing member 9 protrudes from a disc-shaped main body portion 91 and the center portion of the main body portion 91, enters the medicine container connection portion 94 of the adapter, and the nozzle portion of the outer cylinder 6. 62 is provided with a projecting portion 92 that can come into contact with the front end surface of 62 and a sealing member collar portion 93 formed so as to surround the projecting portion 92.

Next, a method of using the drug container and syringe of this embodiment will be described with reference to FIGS.
The sealing part 46 of the medicine container 40 and the sealing member 9 of the syringe 15 are detached, and the container body part 41 is connected to the medicine container connection part 94 of the adapter 16 attached to the outer cylinder 6 as shown in FIG. To do. Then, by pulling the plunger 7 attached to the gasket 8 in the proximal direction of the outer cylinder 6, the inside of the container main body 41 is in a negative pressure state, the gasket 42 moves, and the medicine 48 flows into the outer cylinder 6. To do. Then, if necessary, the syringe 15 is shaken while the container body 41 is connected, and the drug is dissolved or mixed in the medical liquid. Then, after the mixing is completed, the upper sheet 3 is peeled off from the label 1 of the medicine container 40 and is affixed to the outer surface of the outer cylinder 6 of the syringe 15. Then, by removing the medicine container 40 together with the adapter 16 from the syringe 15, preparation for administration of the syringe 15 filled with the medicine shown in FIG. 16 is completed. Note that the drug container 40 may remain connected to the syringe 15 immediately before administration. Thereby, the medicine melt | dissolved or mixed from the nozzle part 62 of the syringe 15 does not leak between mixing and administration.

  The drug container may have a tip opening that can be directly connected to the nozzle portion 62 of the syringe 15. Specifically, the distal end opening of the drug container has a female mouth shape into which the nozzle portion 62 can be inserted and can be connected to the inserted nozzle portion 62 in a liquid-tight manner. In this case, the collar portion 43 enclosing the tip opening and the adapter 16 connected to the syringe 15 are omitted. Moreover, it is preferable that a front-end | tip opening part has a chemical | medical agent container side screwing part which can be screwed with an outer cylinder side screwing part.

And in the medicine container having a gasket that slides inside like the medicine container 40 of this embodiment, the display label is like the display label 1c provided in the medicine container 40a shown in FIG. May be.
The display label 1c of this embodiment includes a peeling promotion display 35 that promotes peeling located on the distal end side of the container main body 41. In the following, the same components as those in the above-described embodiment are denoted by the same reference numerals in the drawings, and the description thereof is omitted.

  In the drug container 40a as in the above-described embodiment, the gasket 42 gradually moves in the direction of the distal end opening 45 as the drug moves to the syringe 15 during use. And the gasket 42 reaches | attains the front-end | tip of the main-body part 41 of the chemical | medical agent container 40a in the state which all the chemical | medical agents moved.

  As shown in FIG. 17, the display label 1c of this embodiment is the adapter 16 at the time of use (when connected to the syringe 15), that is, the end of the display label 1b on the tip side of the medicine container 40a. At the end, a peeling promotion display 35 that promotes peeling located at the tip side of the container main body 41 is provided. In the label 1c of this embodiment, the peeling promotion display 35 is character information (specifically, “here”) attached to the extended portion 34 extending from the upper sheet 3c to the end portion on the distal end side of the medicine container 40a. If it comes up, it will be removed.)).

  Further, in the label 1c of this embodiment, the extending part 34 is formed so that the vertical width is shorter than the vertical width of the main body of the display label 1c in plan view. From the vertical gap 34, the gasket 42 moved by the medicine injection operation can be seen.

By providing such an exfoliation promotion display 35, the user can recognize that the upper sheet 3c needs to be peeled off, and that the peeling time is when the gasket 42 has reached the position. it can.
That is, the medicine container 40a with the display label 1c attached is connected to the syringe 15, and then the plunger 7 of the syringe 15 is pulled to move the medicine in the medicine container 40a. The position where the movement is completed can be confirmed by the peeling promotion display 35 of the extending portion 34. This display suggests that the upper sheet 3c is peeled from the lower sheet 2 and transferred to the syringe 15 after confirming the completion of the drug movement.

  For this reason, it is possible to prevent the upper sheet from being peeled off and attached to the syringe before the medicine is moved, and the lower sheet 2 is mistakenly marked “used” on the lower side sheet 2 on the medicine container 40a side. It is possible to suppress the side usage status display 24 from being displayed, and it is also possible to reduce the end of the movement operation while the drug movement is insufficient. The display label 1c needs to be attached so that the peeling promotion display 35 is located at a portion corresponding to a predetermined position where the gasket 42 should be stopped.

Further, in the drug container having a gasket that slides inside, such as the drug container 40 of this embodiment, the display label is similar to the display label 1d provided in the drug container 40b shown in FIG. May be.
The display label 1d has the same basic configuration as the display label 1c described above. In this display label 1d, a transparent transmission part 35a is provided in the extending part 34, and the gasket 42 moved to a predetermined position through the transmission part 35a can be confirmed.

Further, in the transmission part 35a, a peeling promotion display 35 composed of characters “peel off when coming up” is described. Before the movement of the gasket 42, the final movement position of the gasket 42 can be confirmed by the peeling promotion display 35. Further, when the gasket 42 is moved to the final movement position, the peel promotion display 35 can prompt the user to be alerted to peel off the upper sheet 3. The peeling promotion display 35 can directly recognize the predetermined position where the gasket 42 should be moved in advance, and the gasket 42 is moved to the predetermined position by checking the gasket 42 moved to the transmitting portion 35a. Can be intuitively recognized.

  In the label 1d of this embodiment, since the gasket 42 can be visually recognized by the transmission part 35a, the width of the extension part 34 is reduced and the moved gasket 42 is confirmed from the gap around the extension part 34. There is no need to make it possible. Therefore, for example, it is possible to increase the vertical width of the extended portion 34, to ensure the strength of the extended portion 34, to more easily pick the extended portion 34, or to promote the extended portion 34 or peeling. For example, the visibility of the display 35 can be further improved, and the convenience as the extension part 34 and the peeling promotion display can be further improved.

Moreover, in the medicine container having a gasket that slides inside like the medicine container 40 of this embodiment, the display label is like the display label 1e provided in the medicine container 40c shown in FIG. 19 and FIG. It may be a thing.
The display label 1e of this embodiment includes a peeling promotion display 36 that promotes peeling located on the distal end side of the container main body 41. In the following, the same components as those in the above-described embodiment are denoted by the same reference numerals in the drawings, and the description thereof is omitted. The peeling promotion display 36 is easily visible or visible when the gasket moves to the part.

The display label 1e has a basic configuration in common with the display label 1c described above.
And the label 1e of this Example is provided with the peeling promotion display 36 in the extension part 34, as shown in FIG.19 and FIG.20. The peeling promotion display 36 is character information “peel”. In the label 1a of this embodiment, the peeling promotion display 36 is easily visible or visible when the gasket 42 is positioned at the site. Specifically, the peeling promotion display 36 is a color that is difficult to distinguish from the color of the medicine container 40c in the state in which the medicine is accommodated, and is easily distinguished from the color of the medicine container 40c in the state in which the gasket 42 is accommodated. Created with possible colors.

  For this reason, as shown in FIG. 19, it is difficult to visually recognize the peeling promotion display 36 in a state where the gasket 42 does not reach the peeling promotion display 36. And as shown in FIG. 20, when the gasket 42 reaches | attains the permeation | transmission part 36a, the peeling promotion display 36 becomes recognizable. For this reason, it can be made to recognize reliably that peeling is required after completion | finish of chemical | medical agent movement, and peeling of the upper side sheet | seat before chemical | medical agent movement can also be prevented more reliably.

Further, in the medicine container having a gasket sliding inside such as the medicine container 40 of this embodiment, the display label is like the display label 1f provided in the medicine container 40d shown in FIGS. It may be a thing.
In the label 1f of this embodiment, the lower sheet 2f is provided with a pre-combination display 26 indicating that it is before mixing provided at the gasket arrangement position, and the visual recognition of the pre-combination display 26 is assisted by the gasket.
As shown in FIGS. 21 and 22, the display label 1f includes a transmission part formed at the flange side end of the drug container 40d of the lower sheet 2f, and further, a pre-combination display 26 is formed in the transparent part. The text information “Liquid” is attached. In other words, in the medicine container 40d of this embodiment, the pre-combination indication 26 of the display label 1f is stuck to the medicine container 40d so as to be on the gasket 42.

In the display label 1f, the upper sheet 3f does not cover the pre-combination display 26 of the lower sheet 2f. For this reason, the pre-combination display 26 is visible regardless of whether the upper sheet 3f is peeled off or not.
In the display label 1f, the pre-combination display 26 remains displayed even when the upper sheet 3f is peeled from the lower sheet 2f before the medicine is moved (before the gasket is moved). It can be confirmed.

  The pre-combination display may be exposed by peeling off the upper sheet 3f. That is, the upper sheet 3f may cover the above-mentioned pre-combination display 26 of the lower sheet 2f and be invisible. In this case, before the medicine is moved (before the gasket is moved), when the upper sheet 3f is peeled from the lower sheet 2f, the pre-combination display 26 is visible, so it is sure that the pre-combination is not performed. It becomes.

Then, in the label 1f of this embodiment, as the medicine moves to the syringe 15, the gasket 42 moves from the position overlapping the pre-combination display 26, that is, from the initial position of the gasket 42, as shown in FIG. Visibility is reduced. Specifically, the pre-combination display 26 is a color that is difficult to distinguish from the color of the medicine container 40d in the state in which the medicine is accommodated, and is easily distinguished from the color of the medicine container 40d in the state in which the gasket 42 is accommodated. Created with possible colors.
Furthermore, as shown in FIG. 23, the label 1f of this embodiment includes a peeling promotion display 36 that can be visually recognized when the gasket 42 arrives, as in the display label 1e described above.

In addition, in a medicine container having a gasket that slides inside, such as the medicine container 40 of this embodiment, the display label is the display label 1g provided in the medicine container 40e shown in FIGS. It may be a thing.
In the label 1g of this embodiment, the lower sheet 2g is provided with a lower sheet side usage status display 27 provided at the gasket arrangement position, and the lower sheet side usage status display 27 is obstructed by the gasket 42. And is visible after the gasket 42 is moved.

The display label 1g of this embodiment is affixed to the medicine container 40e so that the lower sheet side usage status display 27 is on the gasket 42. Specifically, when the usage status display 27 indicating “used” is displayed near the right end of the lower sheet 2g, that is, when the display label is attached to the medicine container 40e, the portion corresponding to the gasket It is described in.

In this embodiment, the lower sheet side usage status display 27 is colored character information and is surrounded by a transparent portion. Conversely, a colored region may be formed and character information indicated by transparent characters therein.
In the label 1g of this embodiment, the lower sheet side usage status display 27 is substantially invisible at the position overlapping the gasket 42, that is, at the initial position of the gasket 42. As shown in FIG. When 42 moves, it becomes visible. Specifically, the usage status display 27 is a color that can be distinguished from the color of the medicine container 40e in the state in which the medicine is accommodated, and is indistinguishable from the color of the medicine container 40e in the state in which the gasket 42 is accommodated. Created in color.

In the label 1g of this embodiment, even if the upper sheet 3f is peeled before the medicine is moved, the lower sheet side usage status display 27 cannot be visually recognized. For this reason, even if the upper sheet is mistakenly peeled off before use, the peeled drug container is not mistaken as a used product. And when the gasket moves, the lower sheet side usage status display 27 can be visually recognized.
Furthermore, as shown in FIG. 25, the label 1g of this embodiment is also provided with a peeling promotion display 36 that can be visually recognized when the gasket 42 arrives, similarly to the display label 1e described above.

The label-filled drug-filled drug container of the present invention can be applied to a prefilled syringe 100 as shown in FIG. The prefilled syringe 100 is effective not for direct administration but for mixed injection into an infusion bag.
The prefilled syringe 100 is attached to the outer cylinder 6, the gasket 8 that is housed in the outer cylinder 6 and is slidable in a liquid-tight state, the medicine filled in the outer cylinder 6, and the proximal end of the gasket 8. The plunger 7, the sealing member 103 that seals the nozzle portion 62 of the outer cylinder 6, and the display label 1 of the present invention attached to the side surface of the outer cylinder 6 are provided.
As the display label 1, the display labels of all the embodiments described above can be used.

DESCRIPTION OF SYMBOLS 1 Display label 2 Lower sheet 3 Upper sheet 22 Lower sheet side medicine information display 24 Upper sheet side usage status display 32 Upper sheet side medicine information display 33 Upper sheet side usage status display

Claims (14)

A drug information display label for sticking to a drug container,
The drug information display label includes a lower sheet to be affixed to a drug container, and an upper sheet that partially or entirely covers the surface of the lower sheet, and can be peeled and affixed to the administration container after peeling. And
The said upper sheet | seat is difficult to visually recognize before peeling from the said lower sheet, and is equipped with the upper sheet side use condition display which becomes visible after peeling, The chemical | medical agent container sticking chemical | medical agent information display label characterized by the above-mentioned. The said upper sheet | seat use condition display is the character information which displays that the chemical | medical agent was mix | blended, The chemical | medical agent container sticking chemical | medical agent information display label of Claim 1. The upper sheet usage status display includes colored character information surrounded by a transparent portion or transparent character information provided in a colored portion,
The lower sheet is provided at a lower portion of the upper sheet usage status display of the upper sheet before being peeled from the lower sheet, and includes a visual restriction unit that prevents visual recognition of the character information. Drug information display label attached to the described drug container. The drug information display label attached to a drug container according to claim 3, wherein the visual restriction part has a color that is difficult to distinguish from the color of the character information. The said upper sheet | seat is equipped with the upper sheet | seat side chemical | medical agent information display which described the information regarding the chemical | medical agent accommodated in the said chemical | medical agent container on the surface, The chemical | medical agent container sticking chemical | medical agent information display label in any one of Claim 1 thru | or 4 . The lower sheet has a peelable print section provided at a lower part of the upper sheet side usage status display of the upper sheet before being peeled from the lower sheet, and the upper sheet side usage status display is The chemical | medical agent container sticking chemical | medical agent information display label of Claim 2 which peels required character information from the said peelable printing part at the time of the peeling of the said upper side sheet | seat. The said lower sheet is provided with the lower sheet | seat side use condition display which can be visually recognized after peeling of the said upper sheet | seat, and can presume that the chemical | medical agent was used. Drug information display label attached to the drug container. The said lower sheet | seat side use condition display is the character information which displays that the chemical | medical agent was used, The chemical | medical agent container sticking chemical | medical agent information display label of Claim 7. The said lower sheet | seat is equipped with the lower sheet | seat side chemical | medical agent information display which described the information regarding the chemical | medical agent accommodated in the said chemical | medical agent container on the surface, The chemical | medical agent container sticking chemical | medical agent information in any one of Claim 1 thru | or 8 Display label. The medicine container sticking medicine information display label according to any one of claims 1 to 9, which is attached to the medicine container, and a medicine container in which the medicine is stored having a container body part and a medicine housed in the container body part. A label-filled drug container consisting of The medicine container in which the medicine is stored includes a sealing portion that seals an opening provided in the container main body, the sealing portion includes an elastic seal member that can be punctured by a puncturing member, and the container main body includes: The medicine container with medicine stored therein includes a sealing part for sealing the opening tip part of the container body part, and the cylindrical body part is slid in a liquid-tight state. The label-containing drug-filled according to claim 10, further comprising: a movable gasket, wherein the drug information display label attached to the drug container includes a peeling promotion display that promotes peeling located on a distal end side of the container main body. Drug container. The label-carrying drug-filled drug container according to claim 11, wherein the peeling promotion display is easily visible or visible when the gasket moves to the site. The lower sheet of the drug information display label attached to the drug container is provided with a pre-combination display indicating that the pre-combination is provided at the gasket arrangement position, and the pre-combination display is assisted by the gasket. The label-containing drug-filled drug container according to claim 11 or 12. The lower sheet is provided with a lower sheet side usage status display provided so as to be positioned on the gasket, and the lower sheet side usage status display is difficult to visually recognize when the gasket is positioned, The label-containing drug-filled drug container according to claim 11 or 12, which is visible by moving the gasket.

Images